Related Experiment Video
Updated: Mar 1, 2026
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.3K
Key points to optimizing management and research on cancer-associated thrombosis
A Carmona-Bayonas1, M Sánchez-Cánovas2, J M Plasencia3
1Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, Calle Marqués de los Vélez s/n, 30008, Murcia, Spain. alberto.carmonabayonas@gmail.com.
Summary
Cancer patients frequently experience thromboembolism, but effective prevention and treatment strategies are lacking. Further research is needed to address knowledge gaps in risk assessment, anticoagulation, and thromboprophylaxis for improved cancer care.
Area of Science:
- Oncology
- Hematology
- Clinical Medicine
Background:
- Thromboembolism is a common and serious complication in cancer patients.
- The link between tumorigenesis and thrombotic risk is established, yet management remains challenging.
Purpose of the Study:
- To identify and address critical knowledge gaps in the prevention and treatment of cancer-related thromboembolism.
- To highlight areas requiring further research for improved patient outcomes.
Main Methods:
- Review of existing literature and clinical practice regarding cancer-related thromboembolism.
- Identification of unresolved issues in risk stratification, thromboprophylaxis, and anticoagulation therapy.
Main Results:
- Significant knowledge gaps exist in validating risk assessment tools (e.g., Ay scale vs. Khorana index).
- Need for standardized predictive biomarkers and risk-adapted clinical trials in thromboprophylaxis.
- Efficacy and safety of direct oral anticoagulants require further evaluation in this population.
- Optimal patient selection for anticoagulation and management in special situations (e.g., prolonged therapy) need clarification.
Conclusions:
- Cancer-related thromboembolism remains a significant clinical challenge with unresolved management questions.
- Addressing these knowledge gaps is crucial for developing effective strategies and improving the care of oncology patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
423
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
423
01:21Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
01:30Venous Thrombosis IV: Nursing Management
324
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
324
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K